ReviewFoods (Basel, Switzerland)2026
Simultaneous Determination of Bisphenol A and Its Analogues in Food Matrixes: Cumulative Exposure Assessment Following New Regulatory Restrictions-A Systematic Review.
Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent scientific evidence confirms that there is no safe threshold for bisphenol A intake, prompting strict regulatory actions and new prohibitions in the European Union. As a result, bisphenol A has increasingly been replaced by other analogues that are also toxic but less regulated and insufficiently studied, posing a new risk to human health due to cumulative exposure. Since food is the primary source of exposure to these compounds, this review aimed to evaluate the most appropriate existing chromatographic methods for their determination under newly introduced near-zero tolerance limits, as well as to assess current cumulative dietary exposure and associated health risks. A systematic literature search was conducted in major scientific databases and relevant regulatory sources covering the period from 2015 to 2025, following PRISMA guidelines. Of the 489 identified publications, 22 met the eligibility criteria for full-text analysis. The findings indicate a clear methodological shift towards simultaneous quantification of multiple bisphenol analogues, with LC-MS/MS emerging as the dominant and most robust analytical technique. Dietary exposure to bisphenol A is expected to decline due to stricter regulations; however, this may trigger a rise in the use of its structural analogues as alternatives. Exposure assessments indicate that combined dietary intake of bisphenol A and its analogues can result in a Hazard Index exceeding 1, primarily due to the substantially reduced Tolerable Daily Intake for bisphenol A. This highlights the need for continuous monitoring under stricter regulatory frameworks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.